Risk of Aspiration Due to Dysphagia - TIGLUTIK (riluzole) - ALS Treatment

Risk of Aspiration Due to Dysphagia - TIGLUTIK (riluzole) - ALS Treatment

4.7
(128)
Écrire un avis
Plus
€ 17.99
Ajouter au panier
En Stock
Description

Aspiration pneumonia can be dangerous if left untreated. It is one of the leading causes of hospitalization and the second leading cause of death in ALS.

PDF) Riluzole Oral Suspension: Bioavailability Following Percutaneous Gastrostomy Tube-modeled Administration Versus Direct Oral Administration

IJERPH, Free Full-Text

Diagnostic evaluation of dysphagia Nature Reviews Gastroenterology & Hepatology

Dysphagia Causes & Symptoms + 6 Natural Treatments - Dr. Axe

Evaluating Dysphagia

Consensus on the treatment of dysphagia in Parkinson's disease - Journal of the Neurological Sciences

The assessment of dysphagia after stroke: state of the art and future directions - The Lancet Neurology

TIGLUTIK (riluzole) - ALS Treatment - Patients

Amyotrophic Lateral Sclerosis (ALS)

Evaluation of Swallow

Diagnosis and treatment of neurogenic dysphagia – S1 guideline of the German Society of Neurology, Neurological Research and Practice

Evaluation and Treatment of Swallowing Impairments